UHRF1 and hepatocellular carcinoma: Patients with elevated UHRF1 expression had a shorter relapse-free survival time (P < 0.05) as indicated by Kaplan-Meier analysis (Figure 1D and 1E), indicating that UHRF1 may be a promising biomarker for predicting outcomes of HCC patients.